🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Preclinical studies have demonstrated in mouse models that (PYR1)-apelin-13...
Status
Completed
Location
University Hospitals of Toulouse (Rangueil)
Start Date
2016-05
Trial ID
NCT02724566
Apelin is an endogenous peptide with physiological actions in the cardiovas...
Status
Completed
Location
Clinical Research Facility University of Edinburgh
Start Date
2014-11
Trial ID
NCT02259686
Chronic kidney disease (CKD) affects 8-16% of the world's population, and i...
Status
Completed
Location
Clinical Research Centre, Western General Hospital
Start Date
2020-02-04
Trial ID
NCT03956576
Treatments Being Tested
The apelin-APJ system is a relatively new discovery. It has generated inter...
Status
Completed
Location
Clincial Research Facility, Royal Infirmary of Edinburgh, 51 Little France Cresc
Start Date
2010-04
Trial ID
NCT00901719
Treatments Being Tested
The investigators are interested in studying how Pulmonary Hypertension occ...
Status
Completed
Location
Vascular Research Unit, Clinical Pharmacology Unit, ACCI, Level 3, Addenbrooke's Hospital, Hills Road
Start Date
2014-06
Trial ID
NCT02129309
Treatments Being Tested
Hyponatremia is a common electrolyte imbalance which often results from hor...
Status
Completed
Location
University Hospital Basel
Start Date
2024-03-01
Trial ID
NCT06277336
Treatments Being Tested
The (PYR1)-apelin-13 is an endogenous peptide discovered relatively recentl...
Status
Completed
Location
University Hospital of Toulouse
Start Date
2014-01
Trial ID
NCT02033473
The apelin-APJ system is a relatively new discovery. It has generated inter...
Status
Completed
Location
Clincial Research Facility, Royal Infirmary of Edinburgh, 51 Little France Cresc
Start Date
2009-04
Trial ID
NCT00901888
Treatments Being Tested
The purpose of this study was to determine the safety and tolerability of C...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-05-17
Trial ID
NCT02696967
The purpose of this study is to * Determine blood peptide levels and inves...
Status
Completed
Location
Hammersmith Hospital, Imperial College London
Start Date
2012-03
Trial ID
NCT01590108
Treatments Being Tested